RECENT NEWS

Laboratories at four trusts, in Buckinghamshire, Milton Keynes, Oxfordshire and Swindon, will use WinPath Enterprise to deliver a consistent, high-quality and equitable service and build a platform for innovation.

Consultant biomedical scientist roles are no longer the rarity they once were. RCPath/IBMS examinations in cellular pathology have begun to open career pathways that will allow these roles to become more commonplace over time, as Guy Orchard explains

SHOT and the MHRA will hold a joint webinar on 19 May, 1300–1400 BST, on the importance of learning from Near Miss events and the principles of Investigating Incidents. It will also include illustrative cases to highlight key learning points.

Thermo Fisher Scientific has launched a CO2 incubator that combines optimal cell growth capabilities with certified cleanroom compatibility, addressing the need for high-performance incubation systems that meet stringent cleanroom and cGMP standards.

Beckman Coulter has announced the European launch of the DxA 5000 Fit, a workflow automation solution designed to fit into medium-sized laboratories that run fewer than 5000 tests a day.

CytoSMART Technologies has announced the release of its first fluorescence cell counter. The CytoSMART Exact FL is an automated, dual fluorescence cell counter with an expanded field of view and performance.

A test that uses artificial intelligence (AI) to measure proteins present in some patients with advanced bowel cancer could hold the key to more targeted treatment, according to recent research.

LIOFeron-TB/LTBI is an in vitro blood IGRA useful in the detection of Mycobacterium tuberculosis, the bacterium causing tuberculosis (TB), and is intended for use in conjunction with other medical and diagnostic evaluations.

Sysmex UK has recently launched the new CN-Series of analysers, designed to provide a powerful solution and to deliver answers to laboratory haemostasis testing requirements of productivity, services, analytical and operational performance.

The Randox Discovery, an innovative diagnostic analyser that can consolidate molecular and immunoassay testing on one compact benchtop platform, has received the 2021 Red Dot Award for High Design Quality.

AnteoTech has announced that its EuGeni Reader and accompanying COVID-19 Antigen Rapid Test (ART) have received CE-mark registration as the company looks to progress with European distribution.

INTEGRA Biosciences’ VIAFLO electronic pipettes are helping denovoMATRIX in Dresden, Germany, to produce modular, biomimetic coatings for cell culture plasticware that can be tailored to recreate various conditions to test adherent cell cultures.

A study led by The Institute of Cancer Research (ICR) researchers has revealed that death from infection in patients with chronic lymphocytic leukaemia (CLL) is associated with certain gene mutations.

A partnership that will transform pathology services and help to improve the quality of patient care across South East London has gone live.

Dr Sarah Pitt has been made a Life Member of the Institute of Biomedical Science in recognition of her long and valuable contribution to the field of virology.

ViroStat is a primary manufacturer, supplying infectious disease reagents to researchers and rapid test manufacturers. It has just released a new set of monoclonal antibodies to lipoteichoic acid (LTA).

Olympus has unveiled the winners of its second Global Image of the Year Life Science Light Microscopy Award. The winning images were selected from a record number of entries—nearly 700 submissions from 61 countries.

The wide range of Excel Scientific sealing options, available from Alpha Laboratories, securely seal plates to avoid contamination and evaporation. They are designed with features that maximise ease of use and performance in specific techniques.

Sarah May, Deputy Chief Executive at the IBMS, provides a personal view of progress in organising the professional body's next biennial Congress event.

The British In Vitro Diagnostics Association (BIVDA) has launched its new Don’t Wait;Act campaign to re-start testing for non-COVID health issues.